AdaptHealth Corp. (NASDAQ: AHCO) is a Healthcare company (Medical - Devices) with a market capitalization of $1.0B. The Maz Rating grades it against the other companies in its sector.
AdaptHealth Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $7.53, AdaptHealth Corp. trades at 0.3x sales and 0.8x book value, with an EV/EBITDA of 37.1. Over the last twelve months it generated about $3.1B of revenue and a net loss of $405M. It runs a gross margin of 15.3%, an operating margin of -7.4% and a net margin of -12.9%. It shows return on equity of -28.9%, return on invested capital of -6.0% and a free cash flow yield of 8.0%. On the balance sheet: a debt-to-equity ratio of 1.67 and a current ratio of 1.13. Over the past 52 weeks the share price ranged from $5.21 to $13.43, with a beta of 1.36.
AdaptHealth Corp. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 9 Buy, 2 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, AdaptHealth Corp. (AHCO) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 225.6% / 30% · (Cash+Inv) / Mkt Cap (36m) 14.8% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 225.6% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 9.66% / 33% · Receivables / Mkt Cap (36m) 47.4% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 225.6% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 9.66% / 33.33% · Receivables / Mkt Cap (24m) 47.4% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 42.4% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 1.61% / 33.33% · Receivables / Avg Assets (4Q) 8.96% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 44.8% / 33.33% · (Cash+ST Inv) / Total Assets 1.92% / 33.33% · (Cash+Recv) / Total Assets 11.3% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, AdaptHealth Corp. (AHCO) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. AdaptHealth Corp. is over the AAOIFI limit on Debt / Mkt Cap (36m).
AdaptHealth Corp. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.